The stock of Lifecore Biomedical Inc. (NASDAQ:LFCR) last traded at $6.64, up 4.57% from the previous session.
Data from the available sources indicates that Lifecore Biomedical Inc. (NASDAQ:LFCR) is covered by 4 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $16.00 and a low of $11.00, we find $13.00. Given the previous closing price of $6.35, this indicates a potential upside of 104.72 percent. LFCR stock price is now -16.98% away from the 50-day moving average and -29.47% away from the 200-day moving average. The market capitalization of the company currently stands at $194.55M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
In total, 0 analysts have assigned it a hold rating, and 4 have given it a buy rating. Brokers who have rated the stock have averaged $13.25 as their price target over the next twelve months.
.
Insiders disposed of 30,329 shares of company stock worth roughly $0.2 million over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in LFCR stock. A new stake in Lifecore Biomedical Inc. shares was purchased by GSA CAPITAL PARTNERS LLP during the first quarter worth $102,000. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. invested $72,000 in shares of LFCR during the first quarter. In the first quarter, AMALGAMATED FINANCIAL CORP. acquired a new stake in Lifecore Biomedical Inc. valued at approximately $21,000. AQUATIC CAPITAL MANAGEMENT LLC acquired a new stake in LFCR for approximately $16,000.
With an opening price of $6.23 on Tuesday morning, Lifecore Biomedical Inc. (NASDAQ: LFCR) set off the trading day. During the past 12 months, Lifecore Biomedical Inc. has had a low of $5.94 and a high of $12.04. As of last week, the company has a debt-to-equity ratio of 1.47, a current ratio of 1.40, and a quick ratio of 0.60. The fifty day moving average price for LFCR is $7.95 and a two-hundred day moving average price translates $9.39 for the stock.
The company reported revenue of $43.35 million for the quarter, compared to $41.63 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.14 percent.
